Back
Ameren Corp. 10K Form
Buy
76
AEE
Ameren Corp.
Last Price:
$110.96
Seasonality Move:
0.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-29 | 10K | AEE/Ameren Corp. Annual |
| 2023-11-09 | 10Q | AEE/Ameren Corp. Quarterly |
| 2023-08-03 | 10Q | AEE/Ameren Corp. Quarterly |
| 2023-05-05 | 10Q | AEE/Ameren Corp. Quarterly |
| 2023-02-22 | 10K | AEE/Ameren Corp. Annual |
| 2022-11-04 | 10Q | AEE/Ameren Corp. Quarterly |
Receive AEE News And Ratings
See the #1 stock for the next 7 days that we like better than AEE
AEE Financial Statistics
Sales & Book Value
| Annual Sales: | $8.8B |
|---|---|
| Cash Flow: | $-80M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $48.48 |
| Price / Book: | 2.24 |
Profitability
| EPS (TTM): | 5.34850 |
|---|---|
| Net Income (TTM): | $1.5B |
| Gross Margin: | $2.6B |
| Return on Equity: | 11.51% |
| Return on Assets: | 3.14% |
Ameren Corp. Earnings Forecast
Key Ameren Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for AEE is 29.58%.
-
The Selling, General & Administrative Expenses for AEE have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 53.11% of Operating Income.
-
The Net Earning history of AEE is 16.60% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 24 years.
Ameren Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Multi-Utilities |
| Sector: | Utilities |
| Current Symbol: | AEE |
| CUSIP: | 023608 |
| Website: | amereninvestors.com |
Debt
| Debt-to-Equity Ratio: | 1.48 |
|---|---|
| Current Ratio: | 0.66 |
| Quick Ratio: | 0.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.74 |
|---|---|
| Forward P/E Ratio: | 19.09 |
AEE Technical Analysis vs Fundamental Analysis
Buy
76
Ameren Corp. (AEE)
is a Buy
Is Ameren Corp. a Buy or a Sell?
-
Ameren Corp. stock is rated a BuyThe current Ameren Corp. [AEE] share price is $110.97. The Score for AEE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.